This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Selvita S.a.. Active years: 2013-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Brzeg Dolny, PL (2013)
- Brzeg, PL (2016 - 2019)
Company Filing History:
Years Active: 2013-2019
Title: The Innovative Contributions of Aleksandra Sabiniarz
Introduction
Aleksandra Sabiniarz, an accomplished inventor based in Brzeg, Poland, has made significant strides in the field of pharmaceutical innovations. With three patents to her name, Aleksandra's work primarily focuses on the development of benzimidazole derivatives as kinase inhibitors. These innovations hold great potential in the treatment of various diseases, particularly those linked to specific kinases.
Latest Patents
Aleksandra's latest patents revolve around her groundbreaking research into benzimidazole derivatives. The first patent details these derivatives as serine/threonine and tyrosine kinase-inhibitors, particularly targeting PIM1-3 and DYRK1A kinases. These compounds may aid in treating diseases such as leukemias, lymphomas, solid tumors, and autoimmune disorders. This innovation marks a significant advancement in the fight against these serious health issues, highlighting Aleksandra's dedication to improving patient outcomes.
Career Highlights
Aleksandra is currently affiliated with Selvita S.A., a prominent player in the pharmaceutical industry. Her role at this innovative company allows her to further explore and develop her ideas into practical applications. Her work has not only contributed to her reputation as an inventor but also showcases her commitment to advancing therapeutic solutions.
Collaborations
Throughout her career, Aleksandra has collaborated with esteemed colleagues, including Wojciech Czardybon and Krzysztof Brzózka. These partnerships have enabled a sharing of ideas and expertise, driving innovation in their respective fields. Together, they work towards achieving groundbreaking results in pharmaceutical research and development.
Conclusion
Aleksandra Sabiniarz stands out as a talented inventor whose contributions to the field of oncology and therapeutics are noteworthy. Her research on benzimidazole derivatives as kinase inhibitors reflects her innovative spirit and commitment to addressing significant health challenges. As she continues her journey in the pharmaceutical sector, the impact of her work is sure to be felt in the years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile